Literature DB >> 12951347

Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides.

Andrea Giacometti1, Roberto Ghiselli, Oscar Cirioni, Federico Mocchegiani, Fiorenza Orlando, Maria Simona Del Prete, Giuseppina D'Amato, Carmela Silvestri, Vittorio Saba, Giorgio Scalise.   

Abstract

OBJECTIVES: A rat model was used to investigate the efficacy of linezolid, alone or in combination with levofloxacin and vancomycin, in the prevention of vascular prosthetic graft infection resulting from methicillin-resistant Staphylococcus epidermidis with intermediate resistance to glycopeptides.
METHODS: Graft infections were established in the subcutaneous tissue of adult male Wistar rats by implantation of Dacron prostheses, followed by topical inoculation with S. epidermidis. The study comprised: one group without inoculation; one inoculated group without prophylaxis; six inoculated groups that received intraperitoneal linezolid (8 mg/kg), levofloxacin (7 mg/kg) or vancomycin (7 mg/kg) alone or in combination at the dosages mentioned above. Each group included 20 animals. The grafts were removed after 7 days and evaluated by quantitative culture.
RESULTS: Quantitative graft cultures from animals treated with a single drug showed a significant efficacy only for linezolid. The efficacy of levofloxacin was similar to that of vancomycin. Combination studies demonstrated that only the treatments that included linezolid produced no evidence of staphylococcal infection.
CONCLUSIONS: Linezolid as perioperative prophylaxis can be useful for the prevention of graft infections caused by multiresistant staphylococcal strains.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12951347     DOI: 10.1093/jac/dkg396

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

1.  Linezolid in prophylaxis against experimental aortic valve endocarditis due to Streptococcus oralis or Enterococcus faecalis.

Authors:  George Athanassopoulos; Angelos Pefanis; Vissaria Sakka; Dimitrios Iliopoulos; Despina Perrea; Helen Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Which prosthesis is more resistant to vascular graft infection: polytetrafluoroethylene or Omniflow II biosynthetic grafts?

Authors:  Orhan Bozoglan; Bulent Mese; Erdinc Eroglu; Serdal Elveren; Mustafa Gul; Ahmet Celik; Halil Ibrahim Yildirimdemir; Harun Ciralik; Alptekin Yasim
Journal:  Surg Today       Date:  2015-03-06       Impact factor: 2.549

3.  The efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection.

Authors:  Oriana Simonetti; Oscar Cirioni; Federico Mocchegiani; Ivana Cacciatore; Carmela Silvestri; Leonardo Baldassarre; Fiorenza Orlando; Pamela Castelli; Mauro Provinciali; Marco Vivarelli; Erika Fornasari; Andrea Giacometti; Annamaria Offidani
Journal:  Int J Mol Sci       Date:  2013-08-07       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.